Verily Secures $300M, Becomes Independent from Alphabet
Analysis based on 8 articles · First reported Mar 19, 2026 · Last updated Mar 20, 2026
The market is likely to view Alphabet Inc.===Verily's independence and significant funding positively, as it enables greater flexibility and potential for growth in the precision health AI sector. Alphabet's reduced stake may alleviate concerns about data privacy and foster broader collaborations for Alphabet Inc.===Verily within the healthcare industry.
Alphabet Inc.===Verily, formerly an Alphabet Inc. subsidiary, announced a $300 million investment round led by Series X Capital, with participation from Alphabet, UCHealth, and the University of Colorado Anschutz. This funding facilitates Alphabet Inc.===Verily's transition to an independent corporation, Alphabet Inc.===Verily Health Inc., and will accelerate its precision health AI strategy. Alphabet Inc. will now be a significant minority investor, relinquishing its controlling stake. The company plans to expand its AI-native platform for research and care applications, aiming to harmonize healthcare data, generate insights, and deploy actionable intelligence. Alphabet Inc.===Verily has also established commercial partnerships with Samsung Electronics for biomarker development and Salesforce for integrating its platform with Agentforce Health, further solidifying its position in the healthcare technology landscape.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard